5,455
Views
15
CrossRef citations to date
0
Altmetric
Review

All-cause mortality rates in adults with carbapenem-resistant Gram-negative bacterial infections: a comprehensive review of pathogen-focused, prospective, randomized, interventional clinical studies

, , ORCID Icon, ORCID Icon, , , & show all
Pages 707-719 | Received 10 Aug 2021, Accepted 15 Dec 2021, Published online: 12 Jan 2022

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Fangfang Yuan, Weiqiang Xiao, Xiaokun Wang, Yuewen Fu & Xudong Wei. (2023) Clinical Characteristics and Prognosis of Bloodstream Infection with Carbapenem-Resistant Pseudomonas aeruginosa in Patients with Hematologic Malignancies. Infection and Drug Resistance 16, pages 4943-4952.
Read now
Xianzhen Wei, Linlin Li, Meng Li, Hongjie Liang, Yu He & Shan Li. (2023) Risk Factors and Outcomes of Patients with Carbapenem-Resistant Pseudomonas aeruginosa Bloodstream Infection. Infection and Drug Resistance 16, pages 337-346.
Read now
Jie Qin, Chengyun Zou, Jianmin Tao, Tian Wei, Li Yan, Yufei Zhang & Haiying Wang. (2022) Carbapenem Resistant Pseudomonas aeruginosa Infections in Elderly Patients: Antimicrobial Resistance Profiles, Risk Factors and Impact on Clinical Outcomes. Infection and Drug Resistance 15, pages 2301-2314.
Read now

Articles from other publishers (12)

Keith S. Kaye, Thierry Naas, Jason M. Pogue & Gian Maria Rossolini. (2023) Cefiderocol, a Siderophore Cephalosporin, as a Treatment Option for Infections Caused by Carbapenem-Resistant Enterobacterales. Infectious Diseases and Therapy 12:3, pages 777-806.
Crossref
Emanuel Urmann, Paul Stamm & Jonas Wisskirchen. (2023) Cefiderocol bei AML-Patientin mit neutropenischem Infekt durch 4MRGN Klebsiella pneumoniae (VIM-1). DMW - Deutsche Medizinische Wochenschrift 148:04, pages 170-174.
Crossref
Hongchen Zhang, Shanshan Hu, Lingyun Li, Hangbin Jin, Jianfeng Yang, Hongzhang Shen & Xiaofeng Zhang. (2023) Development and Assessment of a Novel Predictive Nomogram to Predict the Risk of Secondary CR-GNB Bloodstream Infections among CR-GNB Carriers in the Gastroenterology Department: A Retrospective Case–Control Study. Journal of Clinical Medicine 12:3, pages 804.
Crossref
Ali AliMohammadi, Nahid Chezani-sharahi, Zahra Asgari Hezaveh, Elnaz Abbasi, Aref Shariati & Ehsanollah Ghaznavi-Rad. (2023) The significant role of Carbapenems-resistant Acinetobacter Baumannii in mortality rate of patients with COVID-19. Vacunas (English Edition) 24:1, pages 13-18.
Crossref
Ali AliMohammadi, Nahid Chezani-sharahi, Zahra Asgari Hezaveh, Elnaz Abbasi, Aref Shariati & Ehsanollah Ghaznavi-Rad. (2023) The significant role of Carbapenems-resistant Acinetobacter Baumannii in mortality rate of patients with COVID-19. Vacunas 24:1, pages 13-18.
Crossref
Hung-Jen Tang, Chi-Chung Chen, Ying-Chen Lu, Hui-Ling Huang, Hung-Jui Chen, Yin-Ching Chuang, Chih-Cheng Lai & Chien-Ming Chao. (2022) The effect of Lactobacillus with prebiotics on KPC-2-producing Klebsiella pneumoniae. Frontiers in Microbiology 13.
Crossref
Shinobu Imai, Norihiko Inoue & Hideaki Nagai. (2022) Economic and clinical burden from carbapenem-resistant bacterial infections and factors contributing: a retrospective study using electronic medical records in Japan. BMC Infectious Diseases 22:1.
Crossref
Matteo Bassetti, Antonio Vena, Nadia Castaldo, Daniele Roberto Giacobbe, Maddalena Peghin & Paolo Antonio Grossi. (2022) Clinical evidence supporting cefiderocol for serious Acinetobacter baumannii infections. Current Opinion in Infectious Diseases 35:6, pages 545-551.
Crossref
Saoussen Oueslati, Pierre Bogaerts, Laurent Dortet, Sandrine Bernabeu, Hend Ben Lakhal, Christopher Longshaw, Youri Glupczynski & Thierry Naas. (2022) In vitro Activity of Cefiderocol and Comparators against Carbapenem-Resistant Gram-Negative Pathogens from France and Belgium. Antibiotics 11:10, pages 1352.
Crossref
María José Contreras-Gómez, José R. W. Martinez, Lina Rivas, Roberto Riquelme-Neira, Juan A. Ugalde, Aniela Wozniak, Patricia García, José M. Munita, Jorge Olivares-Pacheco & Manuel Alcalde-Rico. (2022) Role of the multi-drug efflux systems on the baseline susceptibility to ceftazidime/avibactam and ceftolozane/tazobactam in clinical isolates of non-carbapenemase-producing carbapenem-resistant Pseudomonas aeruginosa. Frontiers in Pharmacology 13.
Crossref
Giorgia Montrucchio, Andrea Costamagna, Tommaso Pierani, Alessandra Petitti, Gabriele Sales, Emanuele Pivetta, Silvia Corcione, Antonio Curtoni, Rossana Cavallo, Francesco Giuseppe De Rosa & Luca Brazzi. (2022) Bloodstream Infections Caused by Carbapenem-Resistant Pathogens in Intensive Care Units: Risk Factors Analysis and Proposal of a Prognostic Score. Pathogens 11:7, pages 718.
Crossref
Anusorn Thampithak, Kessarin Chaisiri, Onrumpa Siangsuebchart, Kamonchanok Phengjaturat, Wiwarin Aonjumras & Jatapat Hemapanpairoa. (2022) Prescription Pattern of Intravenous Fosfomycin in a Provincial Hospital in Thailand. Infection & Chemotherapy 54:4, pages 699.
Crossref